Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- University of Oxford
- Baylor College of Medicine
- Umeå University
- University of Maryland, Baltimore
- University of Washington
- CNRS
- Duke University
- Institut Curie - CNRS
- KINGS COLLEGE LONDON
- Karolinska Institutet
- Oregon State University
- SciLifeLab
- UT southwestern medical center-faculty of medical physics
- University of Cambridge
- University of Rijeka Faculty of Medicine
- Washington University School of Medicine
- 6 more »
- « less
-
Field
-
, scientific field of clinical medical sciences, scientific branch of oncology, at the Department of Oncology and Radiotherapy, Faculty of Medicine in Rijeka, at the teaching hospital Clinical Hospital Center
-
Department: College of Pharmacy, Conroy Sun Lab Location: Portland, Oregon Appointment: 100% Basis: 12-months Notes on start date: As soon as possible Notes on end date: One year with possibility of renewal for up to three years Full announcement: sun_lab_postdoc_4.26.23.pdf
-
Multiple Postdoctoral Positions in Advanced Radiotherapy Research - (220001I0) The Medical Physics team in the Department of Radiation Oncology at the University of Maryland School of Medicine is
-
collaborative project with University of Manchester and NHS to understand the evolution of head and neck tumours (HNC) during radiotherapy treatments, using our innovative and long-term 3D primary culture (human
-
UT southwestern medical center-faculty of medical physics | Dallas, Texas | United States | about 1 month ago
to overocme the challenge of locating soft tissue target or tumors using conventional X-ray image, reduce radiotherapy research uncertainties, and provide quantifiable treatment outcome. The imaging
-
Washington University School of Medicine | Saint Louis, Missouri | United States | about 1 month ago
The Washington University School of Medicine, Department of Radiation Oncology has an opening for a post-doctoral research associate in the Computational Radiotherapy Lab (CORAL) lead by Dr. Geoff
-
contribute to ground-breaking research aimed at enhancing the effectiveness of radiotherapy treatments. Our focus lies in developing innovative approaches to sensitize tumor cells to radiotherapy, with
-
of this project is to develop anticancer molecularly targeted radiotherapy agents (theranostics) for the imaging and treatment of cancer. The focus of the project will be on specific organelle targeting with
-
identify biomarkers for therapy efficacy in sequential blood samples from patients with advanced melanoma receiving immune checkpoint inhibitors alone or in combination with radiotherapy, that is being
-
tissues in a space- and time-controlled resolution. Theranostic prodrugs detectable by nuclear magnetic resonance imaging (MRI) and able to be activated by radiotherapy clinical beams, will be developed